The ASX 200 was caught between a commodity rally and a rate hike squeeze this week, closing out trade unchanged for the trading week.
Will gold prices continue to rip in 2026? The World Gold Council sees the case for more outsized gains if we wind up in a ‘doom loop’.
The ASX healthcare sector has fallen in the week ending December 5, 2025 with Epiminder down in its first week on the Aussie bourse.
Island Pharmaceuticals is strengthening its antiviral IP and progressing key FDA engagement as it advances its Galidesivir program.
Pinnacle Minerals is following the critical minerals trail at the Antimony Queen project in Washington State, US, targeting historical production zones for initial exploration.
Mining giants have fronted investors ahead of Christmas, with Glencore eyeing major copper growth and Rio trying to prove its fitness.
